Prof. Seyed Mohammad Akrami is a Professor of Medical Genetics at Tehran University of Medical Sciences (TUMS), Iran. With over two decades of experience, he has contributed significantly to genetic research, education, and clinical diagnostics. He specializes in molecular and cancer genetics, bioethics, and genetic counseling, actively advancing the field through innovative research and teaching.

• Medical Genetics
• Cancer Genetics
• Medical Ethics

• Detection of a large TBX5 deletion in a family with Holt-Oram syndrome. SM Akrami, RM Winter, JD Brook, and JAL Armour. Journal of Medical Genetics. 2001; 38: e44.
• DNA copy number analysis by Multiplex Amplifiable Probe Hybridization (MAPH): Molecular Diagnostic Applications. EJ Hollox, SM Akrami and JAL Armour. Expert Review of Molecular Diagnostics. 2002; 2(4): 370-378.
• Metabolic and clinical effects of Ramadan fasting in patients with type II diabetes. B Larijani, Sh Yarahmadi, MH Bastanhagh, M Pajouhi, RB Jalili, F Zahedi, K Zendehdel, and SM Akrami. Journal of College of Physicians Surgical Pakistan. 2003; 13(6): 329-32.
• The agreement between QUS and DXA in the diagnosis of osteoporosis. MH Dabaghmanesh, B Larijani, A Soltani, M Pajouhi, SM Akrami, H Adibi, and Z Hamidi. Iranian South Medical Journal. 2002; 5(1): 55-59. [Persian]
• Human Cloning. SM Akrami. Journal of Medical Council of Islamic Republic of Iran. 2003; 21(1): 76-77 [Persian].
• Diagnosis of Gene Dosage Alterations at The PMP22 Gene Using MAPH. SM Akrami, JS Rowland, GR Taylor, and JAL Armour. Journal of Medical Genetics. 2003; 40(11): e123.
• Diagnostic Value of Frozen Section Examination in Thyroid Nodule Surgery at the Shariati Hospital (1997–2000). M Shirzad, B Larijani, A Hedayat, N Kamalian, R Baradar-Jalili, F Bandarian, SM Tavangar, and SM Akrami. Endocrine Pathology. 2003; 14(3): 263-268.
• Gene dosage analysis by multiplex amplifiable probe hybridization. JAL Armour, IA Rad, EJ Hollox, SM Akrami, GS Cross. Methods in Molecular Medicine. 2004; 92: 125-39.
• Effects of levothyroxine suppressive therapy on bone mineral density in premenopausal women. B Larijani, F Gharibdoost, M Pajouhi, A Sadjadi, S Aghakhani, R Eshraghian, SM Akrami, G Maalouf. Journal of Clinical Pharmacology & Therapeutics. 2004; 29(1): 1-5.
• Book Chapter; Genetics of Thyroid Cancer in “Diagnosis and Treatment of Thyroid Cancers, a review of thyroid cancers in Iran” p 41-70. 2004. Tehran; Tehran University of Medical Sciences Publication [Persian].
• Book Chapter; Genetic factors in common diseases in “Genetics of Diseases” p. 243-299. 2004. Tehran; Tehran University of Medical Sciences Publication [Persian].
• Molecular Genetics Laboratory Establishment for Endocrinopathies. SM Akrami, P Amiri. Iranian Journal of Diabetes and Lipid disorders. 2004; 3(2): 207 [Persian].
• Genetics of Holt-Oram Syndrome. SM Akrami, P Amiri. Iranian Journal of Pediatrics. 2003; 13(2): 153- 160 [Persian].
• Brain death: Recent ethical and religious considerations in Iran. SM Akrami, Z Osati, F Zahedi, M Raza. Transplantation Proceedings. 2004; 36(10): 2883-2887.
• A simple method to screen for exonic deletions and duplications in HNPCC genes. SM Akrami, M Dunlop, I Frayling, F Macdonald, J Harvey, JAL Armour. Familial Cancer. 2005; 4(2): 145-149.
• Diabetes mellitus following pituitary adenomectomy in euglycemic patients with acromegaly. B Larijani, M Nakhjavani, R Baradar-Jalili, SM Akrami, F Bandarian. Journal of College of Physicians Surgical Pakistan. 2005; 15(7): 430-32.
• Role of levothyroxine suppressive therapy for benign cold nodules of thyroid: a randomized, double-blind, placebo-controlled clinical trial. B Larijani, M Pajouhi, MH Bastanhagh, A Sadjadi, S Aghakhani, F Zare, N Sedighi, MR Eshraghian, AH Nadjafi, MR Amini, H Adibi, SM Akrami. Therapy. 2005; 2(6): 883-888.
• Insulin production by Human Stem Cells. B Larijani, SM Akrami, MM Amoli. Iranian Journal of Endocrinology and Metabolism. 2005; 7(3): 269-278 [Persian].
• Special Attention in Prenatal Genetic Counseling of Familial Cancer Syndromes. SM Akrami. Medical Journal of Reproduction and Infertility. 2006; 6(5): 563-564 [Persian].
• Review of compiling of ethical guidelines for genetic research in Iran. E Motevasseli, SM Akrami, S Zeinali, MH Modaresi, A Parsapour, K Aramesh, M Mohammadian, B Larijani. Journal of Babol University of Medical Sciences. 2005; 5: 49-54 [Persian].
• Differentiation of Mouse Embryonic Stem Cell into Insulin-Secreting Cell. H Baharvand, H Jafari, M Masoumi, SM Akrami, MS Mola, et al. Journal of Iranian Anatomical Sciences. 2005; 2 (4), 23-31.
• Genetics of Hereditary Nonpolyposis Colorectal Cancer (HNPCC). SM Akrami. Archives of Iranian Medicine. 2006; 9(4): 381 – 389.
• Consanguineous marriage; genetic counseling, culture and religious aspects. SM Akrami. Iranian Journal of Pediatrics. 2006; 16(3): 359- 365 [Persian].
• 24.A common polymorphism in the promoter of UCP2 gene in an Iranian normal population. J Heidari, SM Akrami, R Heshmat, P Amiri, H Fakhrzadeh, M Pajouhi. Iranian Journal of Diabetes and Lipid disorders. 2006; 5(3): 209- 215 [Persian].
• Association study of polymorphism of the PPAR-γ2 gene and obesity. H Mirzaei, T Golmohammadi, SM Akrami, M Doosti, M Nakhjavani, R Heshmat, P Amiri. Iranian Journal of Diabetes and Lipid disorders. 2006; 6(1): 9-16 [Persian].
• Is Consanguineous Marriage Religiously Encouraged? Islam and Iranians Considerations. SM Akrami, Z Osati. Journal of Biosocial Science. 2007; 39(2): 313-316.
• Association Studies in the Common Endocrine Diseases. SM Akrami, J Heidari. Tehran University Medical Journal. 2007; 64(11): 1-10 [Persian].
• Genetic Counseling in Diabetes. SM Akrami. Iranian Journal of Diabetes and Lipid disorders. 2007; 6(3):205-214 [Persian].
• Association study of apoA-I gene polymorphisms and lipid profile and type 2 diabetes in an Iranian population. A Besharati, S.M. Akrami, R. Heshmat, P Yaghmaee. Journal of Medical Council of Islamic Republic of Iran. 2007; 25(2): 132-141 [Persian].
• A 36 years old woman with Hutchinson-Gilford Progeria Syndrome (HGPS): (case report). SM Akrami, GR Yousefzadeh. Tehran University Medical Journal. 2007; 65(9): 77-81 [Persian].
• The Common -866G/A Polymorphism of the UCP2 Gene in Healthy Iranians Compared with World Populations. SM Akrami, J Heidari, R Heshmat, P Amiri, H Fakhrzadeh, M Pajouhi. Human Biology. 2007; 79(1): 103-110.
• Mutation Detection of RET proto-oncogene (Cys634Arg) in an Iranian child. E Alvandi, M Pedram, AR Soroush, B Noorinayer, SM Akrami. Iranian Journal of Pediatrics. 2007; 7(Sup 2):301-305 [Persian].
• Prevalence of consanguineous marriages among patients referred to diabetes and osteoporosis clinics of Dr Shariati hospital, Tehran, Iran. S Rashid Shomali, V Montazeri, SM Akrami, R Heshmat, B Larijani. Iranian Journal of Diabetes and Lipid disorders. 2007; 7(1):85-90 [Persian].
• Case Report of a lady with 13:14 translocation- Special Attention in Prenatal Genetic Counseling of chromosomal translocations. SM Akrami, M Maddah. Medical Journal of Reproduction and Infertility. 2007; 32: 283-286 [Persian].
• Association of Cys 311 Ser Polymorphism of Paraoxonase-2 Gene with the Risk of Coronary Artery Disease. A Jalilian, E Javadi, SM Akrami, H Fakhrzadeh, R Heshmat, M Rahmani, F Bandarian. Archives of Iranian Medicine. 2008; 11 (5): 544 – 549.
• Genetic Counseling in Southern Iran: Consanguinity and Reason for Referral. M Fathzadeh, MA Babaie Bigi, M Bazrgar, M Yavarian, HR Tabatabaee, SM Akrami. Journal of Genetic Counseling. 2008; 17(5):472-9.
• Case report of a patient with Athroembolism and treatment with low level laser. N Kazemikho, SM Akrami, S Mokameli. Medical Laser. 2008; 5(2): 36-38.
• Ethical Dilemmas on the Science of Forensic Genetics. SM Akrami, A Bastani. Iranian Journal of Ethics in Science & Technology. 2008; 3(1,2): 51-60 [Persian].
• Is there a Significant Trend in Prevalence of Consanguineous Marriage in Tehran? A Review of Three Generations. SM Akrami, S Rashid Shomali, V Montazeri, R Heshmat, B Larijani. Journal of Genetic Counseling. 2009; 18(1):82-86.
• Effects study of low level laser therapy on treatment of levels II, III of diabetic foot. N Kazemikho, ME Khamse, F Hashem Dabaghian, M. Hajizade, SM Akrami. Iranian Journal of Diabetes and Lipid disorders. 2009; 8(2): 195-202 [Persian].
• Polymorphism of Pro12Ala in the Peroxisome Proliferator-Activated Receptor gamma2 Gene in Iranian Diabetic and Obese Subjects. H Mirzaei, SM Akrami, T Golmohammadi, M Doosti, R Heshmat, M Nakhjavani, P Amiri. Metab Syndr Relat Disord. 2009; 7(5):453-8.
• Dose L1 Retrotransposition Cause Neuronal Loss in Neurodegenerative Disorders? L Habibi, SM Akrami, MA Shokrgozar. Iran Journal of Medical Hypotheses and Ideas. 2010, 4:4.
• Possible Association of the -866G/A UCP2 gene Promoter Polymorphism with type 2 Diabetes and Obesity in the Iranian population: a case control study. J Heidari, SM Akrami, R Heshmat, P Amiri, H Fakhrzadeh, M Pajouhi. Archives of Iranian Medicine. 2010; 13(5):384-390.
• Preventing medical error in therapeutic abortion. SM Akrami, A Bastani, Z Osati. Journal of Medical Ethics and History of Medicine. 2010; 3(4):27-36 [Persian].
• Molecular Analysis of the RET Proto-Oncogene Key Exons in Medullary Thyroid Carcinoma Patients: A Comprehensive Study of the Iranian Population. E Alvandi, SM Akrami, M Chiani, M Hedayati, B Noori Nayer, MR Mohajeri Tehrani, M Nakhjavani, and M Pedram. Thyroid. 2011; 21(4): 373-382.
• Man evolution: an Islamic point of view. S Ghafouri-Fard and SM Akrami. Eur. J. Sci. Theol. 2011; 7(3): 17-28.
• Blood Donation and Medical Ethics. A Safarifard, S Rivandi, SM Akrami. Journal of Medical Ethics and History of Medicine. 2011; 4(6): 15-26 [Persian].
• Study of low level laser effect on nerve conduction velocity in diabetic neuropathy patients. F Hashem Dabaghian, N Kazemikho, ME Khamse, R Aghili, B Forugh, AO Gushegir, M Malek, M Lajevardi, SM Akrami. Iranian Journal of Diabetes and Lipid disorders. 2011; 11(1):54-59 [Persian].
• 2q34-qter duplication and 4q34.2-qter deletion in a patient with developmental delay. A Rashidi-Nezhad, N Parvaneh, F Farzanfar, C Azimi, L Harewood, SM Akrami, A Reymond. European Journal of Medical Genetics. 2012; 55(3):203-10.
• A comparative study on the prevalence of familial and non – familial Marriages among parents of exceptional children in Tehran. GA Afrooz, E Hakimirad, MGA Lavasani, SAN Kharazi, SM Akrami. Journal of Applied Psycology Research. 2011; 2(1):17-26 [Persian]
• The Role of Ile3434Thr XRCC7 Gene Polymorphism in Differentiated Thyroid Cancer in an Iranian population. R Rahimi, S Fayaz, A Fard-Esfahani, MH Modarressi, SM Akrami, P Fard-Esfahani. Iranian Biomedical Journal. 2012; 16(4):218-22.
• Genetics of consanguineous marriage: Impact and importance of counseling. SM Akrami. Journal of Pediatric Genetics. 2012; 1(4), 217-20.
• Genes or Environment; which one specifies our Future? SM Akrami, A Bastani, MH Moddarresi, F Reihani, V Karmirad. Iranian J of Bioethics. 2012, 2(4); 181-193 [Persian].
• Study of pre, peri and post natal conditions of Iranian patients affected by multiple congenital anomalies. A Rashidi-Nezhad, L Fakhri, S Hantoush Zadeh, E Amini, N Sajjadian, P Hossein Zadeh, F Niknam, SM Akrami. Tehran University Medical Journal, 2013; 70(10): 659-664 [Persian].
• Normal and tumor cervical cells respond differently to vaginal lactobacilli, independent of pH and lactate. E Motevaseli, M Shirzad, SM Akrami, AS Mousavi, A Mirsalehian, MH Modarressi. J Med Microbiol. 2013;62(7):1065-72.
• Effect of Heavy Metals on Silencing of Engineered Long Interspersed Element-1 Retrotransposon Retrotransposon in Nondividing Neuroblastoma Cell Line. L Habibi, MA Shokrgozar, M Motamedi, SM Akrami. Iranian Biomedical Journal. 2013;17(4): 171-8.
• Medical Ethics in Clinical Diagnostic Laboratory. A Safarifard, S Rivandi, SM Akrami. Journal of Medical Council of Islamic Republic of Iran. 2013;31(1):50-60 [Persian].
• Report on attending 9th Global Summit of the National Ethics Committees, Tunisia. SM Akrami. Iranian Journal of Ethics in Science and Technology. 2013; 8(2): 96-97 [Persian].
• A metabolomic study on the effect of intravascular laser blood irradiation on type 2 diabetic patients. N Kazemi Khoo, A Iravani, M Arjmand, F Vahabi, M Lajevardi, SM Akrami, Z Zamani. Lasers in Medical Science. 2013; 28(6):1527-32.
• Mercury specifically induces LINE-1 activity in a human neuroblastoma cell line. L Habibi, MA Shokrgozarb, M Tabrizi, MH Modarressi, SM Akrami. Mutation Research- Genetic Toxicology and Environmental Mutagenesis. 2014; 759, 9–20.
• In vitro Therapeutic Effects of Low Level Laser at mRNA Level on the Release of Skin Growth Factors from Fibroblasts in Diabetic Mice. N Kazemi khoo, MA Shokrgozar, I Ragerdi Kashani, A Amanzadeh, E Mostafavi, H Sanati, L Habibi, S Talebi, M Abouzaripour, and SM Akrami. Avicenna J Med Biotech 2014; 6(2): 113-118.
• Sex Change: Ethical, Islamic Jurisprudence and Legal Aspects. S. Arab, R. Pazokii, SM Akrami. Iranian Journal of Ethics in Science and Technology. 2014; 8(4); 12-23 [Persian].
• Abortion: Ethical and Legal Considerations in Iran (chapter 7; 117-134) by SM Akrami and S Ghafouri-Fard in Biomedical Ethics in Iran; An Application of Islamic Bioethics 2014. AR Bagheri. Published by Eubios Ethics Institute.
• Evaluating the Extent of LINE-1 Mobility Following Exposure to Heavy Metals in HepG2 Cells. A Karimi, Z Madjd, L Habibi, SM Akrami. Biological Trace Element Research. 2014; 160(1):143-151.
• Exposure of Hepatocellular Carcinoma Cells to Low-Level As2O3 Causes an Extra Toxicity Pathway via L1 Retrotransposition Induction. A Karimi, Z Madjd, L Habibi, SM Akrami. Toxicology letters. 2014; 229(1):111-117.
• The effect of homozygous deletion of the BBOX1 and Fibin genes on carnitine level and acyl carnitine profile. A Rashidi-Nezhad, S Talebi, H Saebnouri, SM Akrami, A Reymond. BMC Medical Genetics. 2014;15(1):75.
• miRNA-21 expression analysis in 35 colorectal cancers. N Samadaian, MH Modaresi, M Mobasheri, R Ebrahim Zadeh Vesal, SM Akrami. Tehran Univ Med J. 2014;72(5):301-306 [Persian].
• Retrotransposons and pediatric genetic disorders: importance and implications. SM Akrami, L Habibi. Journal of Pediatric Genetics. 2014; 3(1): 9–16.
• Novel Trends in Genetics: Transposable Elements and Their Application in Medicine. F Vand Rajabpour, R Raoofian, L Habibi, SM Akrami, M Tabrizi. Archives of Iranian Medicine, 2014; 17(10): 702-712.
• Analysis of G>A change in splicing site of intron 6 of XRCC4 gene in patients with differentiated thyroid cancer (DTC). M Rahimi, P Fard-Esfahani, Sh Fayaz, A Fard-Esfahani, MH Modarressi, SM Akrami. ISMJ, 2014; 17(4): 542-549 [Persian].
• Effect of Copper Sulfate on Expression of Endogenous L1 Retrotransposons in HepG2 Cells (Hepatocellular Carcinoma). Karimi A, Majidzadeh-A K, Madjd Z, Akbari A, Habibi L, Akrami SM. Biol Trace Elem Res. 2015; 165(2):131-4.
• Consanguineous marriage from medical genetics, Quran and hadith perspectives. HR Basiri, M Gohari, SM Akrami. Seghlain Journal. 2015; 1(4); 523-542 [Persian].
• Genetic counseling relying on Islamic consultation principles. M Gohari, HR Basiri, SM Akrami. Teb & Tazkieh J. 2014; 23 (3-4): 79-86 [Persian].
• Ethical Challenges of Human Biobanks. M Zaki, A Saber, SM Akrami, A Keramatipur, AR Milanifar. Ethics in Science & Technology. 2015; 10(2): 11-20 [Persian].
• The Effect of Lactobacillus crispatus and Lactobacillus rhamnosus Culture Supernatants on Expression of Autophagy Genes and HPV E6 and E7 Oncogenes in The HeLa Cell Line. E Motevaseli, R Azam, SM Akrami, MA Mazlomy, M Saffari, MH Modarressi, M daneshvar, S Ghafouri-Fard. Cell Journal (Yakhteh) 2016;17(4):601-7.
• Genetic Counseling and Genetic Tests Ethical Challenges. Bereshneh AH, Nejad AS and Akrami SM@. J Clin Res Bioeth. 2015, 6(5): 238.
• Ethical issues in prenatal diagnosis and therapeutic abortion in Iran. A Hosseini Bereshneh, A Salmaninejad, SM Akrami@. Arvand Journal of Health and Medical Sciences. 2016, 1(2): 61-67.
• Low-Level Laser Therapy Along with Intravascular Laser in Deep Pressure Ulcer Resistant to Conventional Therapies. N Kazemikhoo, MR Rahbar, SM Akrami. J Skin Stem Cell. 2015. 2(4):e30686.
• Mitochondrial Copy Number and D-Loop Variants in Pompe Patients. F Bahreini, SM Houshmand, MH Modaressi, H Tonekaboni, S Shahriari, F Nazari, SM Akrami@. Cell Journal (Yakhteh). 2016, 18(3):405-15.
• Association study of rs2228570 SNP of the VDR gene with spermatogenesis disorders in infertile men in Iranian population. M Mohebi, F Karami, MH Modarressi, SM Akrami@. Tehran Uni Med J, 2016, 74(2): 84-91 [Persian].
• Deregulation of miR-1, miR486, and let-7a in cytogenetically normal acute myeloid leukemia: association with NPM1 and FLT3 mutation and clinical characteristics. SS Seyyedi, M Soleimani, M Yaghmaie, M Ajami, M Ajami, S Pourbeyranvand, K Alimoghaddam, SM Akrami@. Tumour Biol. 2016, 37(4):4841-7.
• Aberrant methylation detection of the hMLH1 promoter and the IGF2 DMR region using methylation-sensitive high resolution melting (MS-HRM) in colorectal cancer. R Azizi, M Karimi-Arzenani, M Ghaffarpour, M Tabrizi, S Talebi, H Ajdarkosh, SM Akrami@. Arvand J of Health and Medical Sciences. 2016, 1(3): 142-150.
• Human Identification from the viewpoint of Quran, the innocent ones’ Hadiths and Genetics. M Gohari, HR Basiri, SM Akrami. Med Fiqh J. 2016, 8(26, 27): 175-194 [Persian].
• Ethical issues associated with advanced paternal age and genetic disorders in their offspring. H Yazdekhasti, Z Rajabi, SM Akrami@. Arvand J of Health and Medical Sciences. 2016, 1(4): 191-98.
• Phospho-SMC1 in-Cell ELISA based Detection of Ataxia Telangiectasia. M Zaki dizaji, N Rezaei, M Yaghmaie, M Yaseri, S J Sayedi, G Azizi, A Aghamohammadi, SM Akrami@. Int J Pediatr. 2016, 4(12): 3957-3967.
• Scientific updates in therapeutic interventions of inherited hearing loss. Bereshneh AH, Purmoshir N AS and Akrami SM@. Journal of Medical Council of Islamic Republic of Iran. 2016; 34(4): 347-356 [Persian].
• Prevention of laboratory errors in genetic study and related ethical issues: a case report. H Habibi, M Nekavand, SM Akrami@. Iran Journal of Medical Ethics and History of Medicine. 2017; 9(5): 63-70.
• Ataxia telangiectasia syndrome: moonlighting ATM. M Zaki dizaji, SM Akrami, H Abolhassani, N Rezaei, A Aghamohammadi. Expert Review of Clinical Immunology. 2017; 13(12):1155-1172.
• Molecular changes in obese and depressive patients are similar to neurodegenerative disorders. L Habibi, A Tafakhori, R Hadiani, M Maserat-Mashhadi, Z Kafrash, S Torabi, M Azhdarzadeh, SM Akrami, M Mahmoudi, R Dinarvand. Iran J Neurol. 2017; 16(4):192-200.
• Fetus Sexality from the perspective of the Quran, traditions and embryology. M Gohari, SM Akrami, HR Basiri. Teb & Tazkieh J. 2017; 26 (2): 87-96 [Persian].
• The Study and Analysis of Sexual Cells (Gametes) in Human from the Perspective of Quran. SM Akrami, M Gohari, HR Basiri. Afaq-i Din. 2017; 7(26): 29-54 [Persian].
• Book “The Biological and Genetic Factors on Criminal Behaviors”. A Bastani, SM Akrami, V Karimirad. 2011. Publisher: Mizan Legal Foundation.
• Inflammation, a significant player of Ataxia-Telangiectasia pathogenesis? M Zaki-Dizaji, SM Akrami, G Azizi, H Abolhassani, A Aghamohammadi. Inflamm Res. 2018; 67(7): 559-570.
• Mitochondrial Variants in Pompe Disease: A Comparison between Classic and Non-Classic Forms. F Bahreini, M Houshmand, MH Modarressi, SM Akrami@. Cell J. 2018; 20(3): 333-339.
• Therapeutic effects of a new topical cream formulation in patients with vitiligo. A Shahbazi, M Nikoo, M Habibi, MH Naseh, SM Akrami@, H Choobineh. Surg Cosmet Dermatol. 2018;10(3): 210-15.
• Individual Radiosensitivity Assessment of the Families of Ataxia-Telangiectasia Patients by G2-Checkpoint Abrogation. A Aghamohammadi, SM Akrami, M Yaghmaie, N Rezaei, G Azizi, M Yaseri, H Nosrati, M Zaki-Dizaji. Sultan Qaboos Univ Med J. 2018; 18(4): e440–e446.
• Plasma 5-miRNA as Biomarkers for Identifying Prostate Cancer Patient. M Saffari, MH Modarressi, R Shirkoohi, B Hassani, M Afshrpad, G Rafiei, G Abroodi, MS Yekaninejad, J Arfaee, SM Akrami@. Iran J Public Health. 2019;48(9): 1743-1745.
• One-Year Follow-Up of Vitiligo Patients Treated with Autologous Non-Cultured Melanocytes. Shahbazi A, Naseh M H, Habibi M, Shirazi R, Choobineh H, Akrami SM@. Iran Red Crescent Med J. 2020; 22(1): e81990.
• Effect of Class Switch Recombination Defect on the Phenotype of Ataxia-Telangiectasia Patients. Amirifar P, Mozdarani H, Yazdani R, Kiaei F, Moeini Shad T, Shahkarami S, Abolhassani H, Delavari S, Sohani M, Rezaei A, Hassanpour G, Akrami SM@, Aghamohammadi A. Immunol Invest. 2020; 50(2-3): 201-215.
• Possible synergistic effect of air pollution on increasing severity of SARS-CoV-2. L Habibi, M Tannazi, SM Akrami. Researchsquare, 2020, 1-18. researchsquare.com.
• Legal review of fetal health screening and medical abortion in the population rejuvenation plan and family support. Seyed Mohammad Akrami@, Kheyrollah Parvin, Mohaddeseh Razmjoo. Medical Law Journal. 2021; 15(56): 1-12 [Persian].
• The spectrum of ATM gene mutations in Iranian patients with ataxia-telangiectasia. P Amirifar, MR Ranjouri, S Pashangzadeh, M Lavin, R Yazdani, T Moeini Shad, M Mehrmohamadi, F Salami, S Delavari, S Moamer, A Aghamohammadi, SM Akrami, H Abolhassani. Pediatr Allergy Immunol. 2021; 32(6): 1316–1326.
• Overexpression of HPRT1 is associated with poor prognosis in head and neck squamous cell carcinoma. M Ahmadi, M Eftekhari Kenzerki, SM Akrami, et al. FEBS Open Bio. 2021; 11(9): 2525–2540.
• Review of Prenatal Aneuploidy Screening Uptake Rate and Trends in Iran, and Developed Countries. A Najafi, SM Akrami@. Journal of Human Genetics and Genomics. 2019; 3(2): e119314.
• Debates on Down Syndrome Screening in Iran. Najafi A, Akrami SM@. J Human Gen Genom. 2019;3(2): e119316.
• Evaluation of Epidermal Growth Factor Receptor Gene Mutations in an Iranian Population with Non-Small Cell Lung Carcinoma. Salmani H, Yahyaei M, Raoofian R, Irani S, Salahshouri Far I, Akrami SM@. Iran J Public Health. 2022;51(2):450-459.
• Genetic Risk Variants for Class Switching Recombination Defects in Ataxia-Telangiectasia Patients. Amirifar P, Mehrmohamadi M, Ranjouri MR, Akrami SM, Rezaei N, Saberi A, Yazdani R, Abolhassani H, Aghamohammadi A. J Clin Immunol. 2022. 42(1):72-84.
• Circular RNAs in renal cell carcinoma: Functions in tumorigenesis and diagnostic and prognostic potentials. Sayad A, Najafi S, Kashi AH, Hosseini SJ, Akrami SM, Taheri M, Ghafouri-Fard S. Pathol Res Pract. 2022. 229. 153720.
• Exploring the genetic etiology of drug-resistant epilepsy: incorporation of exome sequencing into practice. Mahdiannasser M, Rashidi-Nezhad A, Badv RS, Akrami SM@. Acta Neurol Belg. 2022. 122(6):1457-1468.
• Regulatory Role of Insulin on Endogenous L1 ORF1 and NEFM Gene Expression through PI3K Signaling Pathway Specifically in Neuroblastoma Cell Line. N Sohrabi, L Habibi, SM Akrami@. Iranian Journal of Public Health. 2023. 52(3): 633-645.
• Demographic and clinical information of patients with non-small cell lung cancer and its relationship with EGFR gene mutation rates in Iranian population. M Yahyaei, I Salahshouri Far, S Irani, SM Akrami@. Journal of Medical Council of IRI. 2022; 40(1): 38-45.
• The challenges in the interpretation of genetic variants detected by genomics techniques in patients with congenital anomalies. H Vaseghi, SM Akrami, A Rashidi-Nezhad. J Clin Lab Anal. 2023; e24967. 37(17-18).
• Towards solving the genetic diagnosis odyssey in Iranian patients with congenital anomalies. P Vaseghi,…, SM Akrami, A Rashidi-Nezhad. Eur J Hum Genet. 2024 Jan 26. Online ahead of print.
• The immunopathological landscape of human pre-TCRα deficiency: From rare to common variants. Materna M, Delmonte OM, Bosticardo M, ..., Akrami SM, ..., Béziat V. Science. 2024; 383(6686):eadh4059.
• Ovarian cancer extracellular vesicle biomarkers. Z Jamali, M Razipour, M Zargar, H Ghasemnejad-Berenji, SM Akrami@. Clinica Chimica Acta. 2025; 565, 120011.
• Identifying Hub Genes and Pathways in Pancreatic Ductal Adenocarcinoma (PAAD): A comprehensive in silico study. E Karimi, NS Kalaki, SM Akrami@. Biochemistry and Biophysics Reports. 2025 March; 41, 101921.

No content available to display!!!

• https://orcid.org/0000-0003-0169-0202